Global CPM - CH - Phase III
Start Date: ASAP
NonStop are looking to speak with Clinical Project Managers in Switzerland, we currently have an opportunity to join a growing biotech in Basel, due to substantial growth in recent times they are looking to strengthen their team with a Clinical Project Manager on a contract or permanent basis. There are many advantages to joining an expanding company, mainly because of the support you will get to grow and develop with them, which will lead to internal opportunities in the future.
They are looking for someone to drive their Phase III study forward so require global project management experience and vendor management. With a focus on antibiotics, you will be part of this interesting study and look to drive the project forward to commercialisation, a key part of the business.
Apply now as we have interview dates for this week and next.
The key requirements are:
- Global experience within Clinical Trials
- Phase III project management
- Experience with dealing with external vendors
- Able to work office based in Basel
Key Words: CPM, Clinical Project Manager, Basel, Switzerland, Antibiotics, Clinical, Oncology, Phase III, Biotech, Biotechnology
Call me Daniel Watson at NonStop Recruitment now for a confidential conversation. Contact me on D.Watson@nonstop-recruitment.com or +41 435 080 817, please send your CV in word format OR if this does not sound like the opportunity for you, but you are a clinical research professional within the pharmaceutical, medical device or biotech industry, please feel free to get in touch, to see other opportunities we may have within this field.
NonStop is one of the largest and fastest growing specialised life sciences recruitment companies in Europe. We are proud members of the APSCo life sciences group who ensure we meet the highest quality standards within the recruitment industry. Our offices are located in the UK, Switzerland and the Czech Republic and we hold labour leasing licences across Europe. Please visit our website for a full list of the niche markets we cover.